 | • レポートコード：MRC2-11QY04050 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、91ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は腫瘍溶解性ウイルス免疫療法のグローバル市場について調査・分析したレポートです。種類別（腫瘍溶解性ウイルスエンジニアリング、野生型腫瘍溶解性ウイルス）市場規模、用途別（病院、クリニック、外来外科センター）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別腫瘍溶解性ウイルス免疫療法の競争状況、市場シェア ・世界の腫瘍溶解性ウイルス免疫療法市場：種類別市場規模 2015年-2020年（腫瘍溶解性ウイルスエンジニアリング、野生型腫瘍溶解性ウイルス） ・世界の腫瘍溶解性ウイルス免疫療法市場：種類別市場規模予測 2021年-2026年（腫瘍溶解性ウイルスエンジニアリング、野生型腫瘍溶解性ウイルス） ・世界の腫瘍溶解性ウイルス免疫療法市場：用途別市場規模 2015年-2020年（病院、クリニック、外来外科センター） ・世界の腫瘍溶解性ウイルス免疫療法市場：用途別市場規模予測 2021年-2026年（病院、クリニック、外来外科センター） ・北米の腫瘍溶解性ウイルス免疫療法市場分析：米国、カナダ ・ヨーロッパの腫瘍溶解性ウイルス免疫療法市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの腫瘍溶解性ウイルス免疫療法市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の腫瘍溶解性ウイルス免疫療法市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの腫瘍溶解性ウイルス免疫療法市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Merck、Amgen、TILT Biotherapeutics、Oncorus、Sorrento Therapeutics、Shanghai Sunway Biotech ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Oncology Immunotherapy exploits virus’s ability to replicate selectively and kill tumor tissue while at the same time regulate the specific immune response of a patient The first oncolytic virus to demonstrate a clinical benefit in patients with melanoma is genetically modified herpes simplex virus type I i.e. Talimogene laherparepvec (T-VEC).
North America is leading in the oncolytic virus immunotherapy market globally, according to Skin Cancer Foundation Statistics, Globally 132,000 melanoma skin cancers occur each year. One in every three cancers diagnosed is a skin cancer, and one in every five Americans will develop skin cancer in their lifetime. North America has well-developed healthcare infrastructure with massive investment in research and development of oncolytic virus immunotherapy.
Market Analysis and Insights: Global Oncolytic Virus Immunotherapy Market
The global Oncolytic Virus Immunotherapy market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Oncolytic Virus Immunotherapy Scope and Market Size
Oncolytic Virus Immunotherapy market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Oncolytic Virus Immunotherapy market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
Merck
Amgen
TILT Biotherapeutics
Oncorus
Sorrento Therapeutics
Shanghai Sunway Biotech
…
Market segment by Type, the product can be split into
Engineering Oncolytic Viruses
Wild-Type Oncolytic Viruses
Market segment by Application, split into
Hospitals
Clinics
Ambulatory Surgical Centers
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Oncolytic Virus Immunotherapy Revenue
1.4 Market by Type
1.4.1 Global Oncolytic Virus Immunotherapy Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Engineering Oncolytic Viruses
1.4.3 Wild-Type Oncolytic Viruses
1.5 Market by Application
1.5.1 Global Oncolytic Virus Immunotherapy Market Share by Application: 2020 VS 2026
1.5.2 Hospitals
1.5.3 Clinics
1.5.4 Ambulatory Surgical Centers
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Oncolytic Virus Immunotherapy Market Perspective (2015-2026)
2.2 Global Oncolytic Virus Immunotherapy Growth Trends by Regions
2.2.1 Oncolytic Virus Immunotherapy Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Oncolytic Virus Immunotherapy Historic Market Share by Regions (2015-2020)
2.2.3 Oncolytic Virus Immunotherapy Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Oncolytic Virus Immunotherapy Market Growth Strategy
2.3.6 Primary Interviews with Key Oncolytic Virus Immunotherapy Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Oncolytic Virus Immunotherapy Players by Market Size
3.1.1 Global Top Oncolytic Virus Immunotherapy Players by Revenue (2015-2020)
3.1.2 Global Oncolytic Virus Immunotherapy Revenue Market Share by Players (2015-2020)
3.1.3 Global Oncolytic Virus Immunotherapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Oncolytic Virus Immunotherapy Market Concentration Ratio
3.2.1 Global Oncolytic Virus Immunotherapy Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Oncolytic Virus Immunotherapy Revenue in 2019
3.3 Oncolytic Virus Immunotherapy Key Players Head office and Area Served
3.4 Key Players Oncolytic Virus Immunotherapy Product Solution and Service
3.5 Date of Enter into Oncolytic Virus Immunotherapy Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Oncolytic Virus Immunotherapy Historic Market Size by Type (2015-2020)
4.2 Global Oncolytic Virus Immunotherapy Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Oncolytic Virus Immunotherapy Market Size by Application (2015-2020)
5.2 Global Oncolytic Virus Immunotherapy Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Oncolytic Virus Immunotherapy Market Size (2015-2020)
6.2 Oncolytic Virus Immunotherapy Key Players in North America (2019-2020)
6.3 North America Oncolytic Virus Immunotherapy Market Size by Type (2015-2020)
6.4 North America Oncolytic Virus Immunotherapy Market Size by Application (2015-2020)
7 Europe
7.1 Europe Oncolytic Virus Immunotherapy Market Size (2015-2020)
7.2 Oncolytic Virus Immunotherapy Key Players in Europe (2019-2020)
7.3 Europe Oncolytic Virus Immunotherapy Market Size by Type (2015-2020)
7.4 Europe Oncolytic Virus Immunotherapy Market Size by Application (2015-2020)
8 China
8.1 China Oncolytic Virus Immunotherapy Market Size (2015-2020)
8.2 Oncolytic Virus Immunotherapy Key Players in China (2019-2020)
8.3 China Oncolytic Virus Immunotherapy Market Size by Type (2015-2020)
8.4 China Oncolytic Virus Immunotherapy Market Size by Application (2015-2020)
9 Japan
9.1 Japan Oncolytic Virus Immunotherapy Market Size (2015-2020)
9.2 Oncolytic Virus Immunotherapy Key Players in Japan (2019-2020)
9.3 Japan Oncolytic Virus Immunotherapy Market Size by Type (2015-2020)
9.4 Japan Oncolytic Virus Immunotherapy Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Oncolytic Virus Immunotherapy Market Size (2015-2020)
10.2 Oncolytic Virus Immunotherapy Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Oncolytic Virus Immunotherapy Market Size by Type (2015-2020)
10.4 Southeast Asia Oncolytic Virus Immunotherapy Market Size by Application (2015-2020)
11 India
11.1 India Oncolytic Virus Immunotherapy Market Size (2015-2020)
11.2 Oncolytic Virus Immunotherapy Key Players in India (2019-2020)
11.3 India Oncolytic Virus Immunotherapy Market Size by Type (2015-2020)
11.4 India Oncolytic Virus Immunotherapy Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Oncolytic Virus Immunotherapy Market Size (2015-2020)
12.2 Oncolytic Virus Immunotherapy Key Players in Central & South America (2019-2020)
12.3 Central & South America Oncolytic Virus Immunotherapy Market Size by Type (2015-2020)
12.4 Central & South America Oncolytic Virus Immunotherapy Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Merck
13.1.1 Merck Company Details
13.1.2 Merck Business Overview
13.1.3 Merck Oncolytic Virus Immunotherapy Introduction
13.1.4 Merck Revenue in Oncolytic Virus Immunotherapy Business (2015-2020))
13.1.5 Merck Recent Development
13.2 Amgen
13.2.1 Amgen Company Details
13.2.2 Amgen Business Overview
13.2.3 Amgen Oncolytic Virus Immunotherapy Introduction
13.2.4 Amgen Revenue in Oncolytic Virus Immunotherapy Business (2015-2020)
13.2.5 Amgen Recent Development
13.3 TILT Biotherapeutics
13.3.1 TILT Biotherapeutics Company Details
13.3.2 TILT Biotherapeutics Business Overview
13.3.3 TILT Biotherapeutics Oncolytic Virus Immunotherapy Introduction
13.3.4 TILT Biotherapeutics Revenue in Oncolytic Virus Immunotherapy Business (2015-2020)
13.3.5 TILT Biotherapeutics Recent Development
13.4 Oncorus
13.4.1 Oncorus Company Details
13.4.2 Oncorus Business Overview
13.4.3 Oncorus Oncolytic Virus Immunotherapy Introduction
13.4.4 Oncorus Revenue in Oncolytic Virus Immunotherapy Business (2015-2020)
13.4.5 Oncorus Recent Development
13.5 Sorrento Therapeutics
13.5.1 Sorrento Therapeutics Company Details
13.5.2 Sorrento Therapeutics Business Overview
13.5.3 Sorrento Therapeutics Oncolytic Virus Immunotherapy Introduction
13.5.4 Sorrento Therapeutics Revenue in Oncolytic Virus Immunotherapy Business (2015-2020)
13.5.5 Sorrento Therapeutics Recent Development
13.6 Shanghai Sunway Biotech
13.6.1 Shanghai Sunway Biotech Company Details
13.6.2 Shanghai Sunway Biotech Business Overview
13.6.3 Shanghai Sunway Biotech Oncolytic Virus Immunotherapy Introduction
13.6.4 Shanghai Sunway Biotech Revenue in Oncolytic Virus Immunotherapy Business (2015-2020)
13.6.5 Shanghai Sunway Biotech Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Oncolytic Virus Immunotherapy Key Market Segments
Table 2. Key Players Covered: Ranking by Oncolytic Virus Immunotherapy Revenue
Table 3. Ranking of Global Top Oncolytic Virus Immunotherapy Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Oncolytic Virus Immunotherapy Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Engineering Oncolytic Viruses
Table 6. Key Players of Wild-Type Oncolytic Viruses
Table 7. Global Oncolytic Virus Immunotherapy Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 8. Global Oncolytic Virus Immunotherapy Market Size by Regions (US$ Million): 2020 VS 2026
Table 9. Global Oncolytic Virus Immunotherapy Market Size by Regions (2015-2020) (US$ Million)
Table 10. Global Oncolytic Virus Immunotherapy Market Share by Regions (2015-2020)
Table 11. Global Oncolytic Virus Immunotherapy Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 12. Global Oncolytic Virus Immunotherapy Market Share by Regions (2021-2026)
Table 13. Market Top Trends
Table 14. Key Drivers: Impact Analysis
Table 15. Key Challenges
Table 16. Oncolytic Virus Immunotherapy Market Growth Strategy
Table 17. Main Points Interviewed from Key Oncolytic Virus Immunotherapy Players
Table 18. Global Oncolytic Virus Immunotherapy Revenue by Players (2015-2020) (Million US$)
Table 19. Global Oncolytic Virus Immunotherapy Market Share by Players (2015-2020)
Table 20. Global Top Oncolytic Virus Immunotherapy Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Oncolytic Virus Immunotherapy as of 2019)
Table 21. Global Oncolytic Virus Immunotherapy by Players Market Concentration Ratio (CR5 and HHI)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Oncolytic Virus Immunotherapy Product Solution and Service
Table 24. Date of Enter into Oncolytic Virus Immunotherapy Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Oncolytic Virus Immunotherapy Market Size by Type (2015-2020) (Million US$)
Table 27. Global Oncolytic Virus Immunotherapy Market Size Share by Type (2015-2020)
Table 28. Global Oncolytic Virus Immunotherapy Revenue Market Share by Type (2021-2026)
Table 29. Global Oncolytic Virus Immunotherapy Market Size Share by Application (2015-2020)
Table 30. Global Oncolytic Virus Immunotherapy Market Size by Application (2015-2020) (Million US$)
Table 31. Global Oncolytic Virus Immunotherapy Market Size Share by Application (2021-2026)
Table 32. North America Key Players Oncolytic Virus Immunotherapy Revenue (2019-2020) (Million US$)
Table 33. North America Key Players Oncolytic Virus Immunotherapy Market Share (2019-2020)
Table 34. North America Oncolytic Virus Immunotherapy Market Size by Type (2015-2020) (Million US$)
Table 35. North America Oncolytic Virus Immunotherapy Market Share by Type (2015-2020)
Table 36. North America Oncolytic Virus Immunotherapy Market Size by Application (2015-2020) (Million US$)
Table 37. North America Oncolytic Virus Immunotherapy Market Share by Application (2015-2020)
Table 38. Europe Key Players Oncolytic Virus Immunotherapy Revenue (2019-2020) (Million US$)
Table 39. Europe Key Players Oncolytic Virus Immunotherapy Market Share (2019-2020)
Table 40. Europe Oncolytic Virus Immunotherapy Market Size by Type (2015-2020) (Million US$)
Table 41. Europe Oncolytic Virus Immunotherapy Market Share by Type (2015-2020)
Table 42. Europe Oncolytic Virus Immunotherapy Market Size by Application (2015-2020) (Million US$)
Table 43. Europe Oncolytic Virus Immunotherapy Market Share by Application (2015-2020)
Table 44. China Key Players Oncolytic Virus Immunotherapy Revenue (2019-2020) (Million US$)
Table 45. China Key Players Oncolytic Virus Immunotherapy Market Share (2019-2020)
Table 46. China Oncolytic Virus Immunotherapy Market Size by Type (2015-2020) (Million US$)
Table 47. China Oncolytic Virus Immunotherapy Market Share by Type (2015-2020)
Table 48. China Oncolytic Virus Immunotherapy Market Size by Application (2015-2020) (Million US$)
Table 49. China Oncolytic Virus Immunotherapy Market Share by Application (2015-2020)
Table 50. Japan Key Players Oncolytic Virus Immunotherapy Revenue (2019-2020) (Million US$)
Table 51. Japan Key Players Oncolytic Virus Immunotherapy Market Share (2019-2020)
Table 52. Japan Oncolytic Virus Immunotherapy Market Size by Type (2015-2020) (Million US$)
Table 53. Japan Oncolytic Virus Immunotherapy Market Share by Type (2015-2020)
Table 54. Japan Oncolytic Virus Immunotherapy Market Size by Application (2015-2020) (Million US$)
Table 55. Japan Oncolytic Virus Immunotherapy Market Share by Application (2015-2020)
Table 56. Southeast Asia Key Players Oncolytic Virus Immunotherapy Revenue (2019-2020) (Million US$)
Table 57. Southeast Asia Key Players Oncolytic Virus Immunotherapy Market Share (2019-2020)
Table 58. Southeast Asia Oncolytic Virus Immunotherapy Market Size by Type (2015-2020) (Million US$)
Table 59. Southeast Asia Oncolytic Virus Immunotherapy Market Share by Type (2015-2020)
Table 60. Southeast Asia Oncolytic Virus Immunotherapy Market Size by Application (2015-2020) (Million US$)
Table 61. Southeast Asia Oncolytic Virus Immunotherapy Market Share by Application (2015-2020)
Table 62. India Key Players Oncolytic Virus Immunotherapy Revenue (2019-2020) (Million US$)
Table 63. India Key Players Oncolytic Virus Immunotherapy Market Share (2019-2020)
Table 64. India Oncolytic Virus Immunotherapy Market Size by Type (2015-2020) (Million US$)
Table 65. India Oncolytic Virus Immunotherapy Market Share by Type (2015-2020)
Table 66. India Oncolytic Virus Immunotherapy Market Size by Application (2015-2020) (Million US$)
Table 67. India Oncolytic Virus Immunotherapy Market Share by Application (2015-2020)
Table 68. Central & South America Key Players Oncolytic Virus Immunotherapy Revenue (2019-2020) (Million US$)
Table 69. Central & South America Key Players Oncolytic Virus Immunotherapy Market Share (2019-2020)
Table 70. Central & South America Oncolytic Virus Immunotherapy Market Size by Type (2015-2020) (Million US$)
Table 71. Central & South America Oncolytic Virus Immunotherapy Market Share by Type (2015-2020)
Table 72. Central & South America Oncolytic Virus Immunotherapy Market Size by Application (2015-2020) (Million US$)
Table 73. Central & South America Oncolytic Virus Immunotherapy Market Share by Application (2015-2020)
Table 74. Merck Company Details
Table 75. Merck Business Overview
Table 76. Merck Product
Table 77. Merck Revenue in Oncolytic Virus Immunotherapy Business (2015-2020) (Million US$)
Table 78. Merck Recent Development
Table 79. Amgen Company Details
Table 80. Amgen Business Overview
Table 81. Amgen Product
Table 82. Amgen Revenue in Oncolytic Virus Immunotherapy Business (2015-2020) (Million US$)
Table 83. Amgen Recent Development
Table 84. TILT Biotherapeutics Company Details
Table 85. TILT Biotherapeutics Business Overview
Table 86. TILT Biotherapeutics Product
Table 87. TILT Biotherapeutics Revenue in Oncolytic Virus Immunotherapy Business (2015-2020) (Million US$)
Table 88. TILT Biotherapeutics Recent Development
Table 89. Oncorus Company Details
Table 90. Oncorus Business Overview
Table 91. Oncorus Product
Table 92. Oncorus Revenue in Oncolytic Virus Immunotherapy Business (2015-2020) (Million US$)
Table 93. Oncorus Recent Development
Table 94. Sorrento Therapeutics Company Details
Table 95. Sorrento Therapeutics Business Overview
Table 96. Sorrento Therapeutics Product
Table 97. Sorrento Therapeutics Revenue in Oncolytic Virus Immunotherapy Business (2015-2020) (Million US$)
Table 98. Sorrento Therapeutics Recent Development
Table 99. Shanghai Sunway Biotech Company Details
Table 100. Shanghai Sunway Biotech Business Overview
Table 101. Shanghai Sunway Biotech Product
Table 102. Shanghai Sunway Biotech Revenue in Oncolytic Virus Immunotherapy Business (2015-2020) (Million US$)
Table 103. Shanghai Sunway Biotech Recent Development
Table 104. Research Programs/Design for This Report
Table 105. Key Data Information from Secondary Sources
Table 106. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Oncolytic Virus Immunotherapy Market Share by Type: 2020 VS 2026
Figure 2. Engineering Oncolytic Viruses Features
Figure 3. Wild-Type Oncolytic Viruses Features
Figure 4. Global Oncolytic Virus Immunotherapy Market Share by Application: 2020 VS 2026
Figure 5. Hospitals Case Studies
Figure 6. Clinics Case Studies
Figure 7. Ambulatory Surgical Centers Case Studies
Figure 8. Oncolytic Virus Immunotherapy Report Years Considered
Figure 9. Global Oncolytic Virus Immunotherapy Market Size YoY Growth 2015-2026 (US$ Million)
Figure 10. Global Oncolytic Virus Immunotherapy Market Share by Regions: 2020 VS 2026
Figure 11. Global Oncolytic Virus Immunotherapy Market Share by Regions (2021-2026)
Figure 12. Porter's Five Forces Analysis
Figure 13. Global Oncolytic Virus Immunotherapy Market Share by Players in 2019
Figure 14. Global Top Oncolytic Virus Immunotherapy Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Oncolytic Virus Immunotherapy as of 2019
Figure 15. The Top 10 and 5 Players Market Share by Oncolytic Virus Immunotherapy Revenue in 2019
Figure 16. North America Oncolytic Virus Immunotherapy Market Size YoY Growth (2015-2020) (Million US$)
Figure 17. Europe Oncolytic Virus Immunotherapy Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. China Oncolytic Virus Immunotherapy Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Japan Oncolytic Virus Immunotherapy Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Southeast Asia Oncolytic Virus Immunotherapy Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. India Oncolytic Virus Immunotherapy Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Central & South America Oncolytic Virus Immunotherapy Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Bottom-up and Top-down Approaches for This Report
Figure 24. Data Triangulation
Figure 25. Key Executives Interviewed
流行性耳下腺炎ウイルス検査の世界市場（～2026年） Mumps is a contagious disease which affects children as well as adult and it is caused by the mumps virus. Mumps is a type of viral infection that affects the parotid gland which one of the member of saliva producing gland. The swelling in one or both parotid gland is the indication for the mumps. T…- C型肝炎ウイルス（HCV）の世界市場（～2026年） Inflammation of liver causes hepatitis. Hepatitis C is a contagious liver disease caused due to hepatitis C virus. Hepatitis C damages and infects the liver. Hepatitis C is spread as the infected blood comes in contact with non-infected blood. Ranging in severity hepatitis C can cause acute and chro…
- 血液ウイルス検査の世界市場（～2026年） Viral testing is carried out to detect infections caused by viruses by destroying cells of immune system. Viruses breed only in living cells and cause diseases by destructing or injuring the cells they infect, damaging the body's whole immune system, altering the genetic material (DNA) of the cells …
- ヒト免疫不全ウイルス（HIV）の世界市場（～2026年） HIV (Human immunodeficiency virus) is a retrovirus which causes HIV infection and attacks the CD-4 cells (T-cells) in the immune system of human body. HIV reduces the number of T-cells in the body and makes the immune system vulnerable to life-threatening infections and cancers. An infected person c…
- 予防的B型肝炎ウイルスワクチンの世界市場（～2026年） The main objective of hepatitis B immunization strategies is to prevent chronic hepatitis B virus infection and its serious consequences, including liver cirrhosis and hepatocellular cancer. The increasing prevalence and incidence of hepatitis B infection is the dominant factor of driving the growth…